EU funds research into Mindact to cut chemotherapy treatment
This article was originally published in Clinica
Executive Summary
Reducing the need for chemotherapy in women with breast cancer is a key priority now for the European Commission, which is providing Euros7m ($8.47m) for a new TRANS-BIG project, aimed at ensuring breast cancer treatment is better targeted.